Personalized Voice Activated Wellness Assistants for Patients With Heart Failure
| Status: | Recruiting |
|---|---|
| Conditions: | Cardiology |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 3/9/2019 |
| Start Date: | December 10, 2018 |
| End Date: | March 2019 |
| Contact: | Amy Loveland, MA |
| Email: | Amy.Loveland@medstar.net |
| Phone: | 301-560-2937 |
The Alexa+ Study will compare the use of the Amazon Echo Dot with Alexa voice technology in
patients with chronic heart failure to those receiving standard of care heart failure
management on changes in health and patient-centered outcomes.
patients with chronic heart failure to those receiving standard of care heart failure
management on changes in health and patient-centered outcomes.
Integrating data from virtual voice activated assistants (Amazon Echo Dot with Alexa voice
technology), with the rich medical history available in Electronic Health Records (EHR) will
allow a truly customized, interactive, and automated personal healthcare assistant. This
technology will be validated in patients who have chronic heart failure (HF). Half of the
study patients will receive an Amazon Echo Dot (Alexa) enhanced with a HF Care custom Alexa
Skill that is patient-specific, or Alexa+. Data on patient interactions with the device will
be followed for three months. The control groups will receive standard of care (SOC) HF
management. Both study and control groups will receive regular follow up from the HF nurse
and data from all hospital or clinic visits will be captured from the EHR.
technology), with the rich medical history available in Electronic Health Records (EHR) will
allow a truly customized, interactive, and automated personal healthcare assistant. This
technology will be validated in patients who have chronic heart failure (HF). Half of the
study patients will receive an Amazon Echo Dot (Alexa) enhanced with a HF Care custom Alexa
Skill that is patient-specific, or Alexa+. Data on patient interactions with the device will
be followed for three months. The control groups will receive standard of care (SOC) HF
management. Both study and control groups will receive regular follow up from the HF nurse
and data from all hospital or clinic visits will be captured from the EHR.
Inclusion Criteria:
- Heart failure patients seen at the MedStar heart failure clinic and the MedStar
Washington Hospital Center inpatient heart failure service
- At least 18 years of age
- Have access to in-home Wi-Fi
Exclusion Criteria:
- Participation in another interventional clinical trial
We found this trial at
1
site
Click here to add this to my saved trials
